Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MedAdvisor Limited ( (AU:MDR) ) has issued an announcement.
MedAdvisor Limited has appointed Mr. Sean Slattery as the new Chief Financial Officer and Company Secretary, effective July 21, 2025. Mr. Slattery, who previously served as CFO at Rhinomed Limited, will play a crucial role in MedAdvisor’s strategic review, which includes the potential sale of its U.S. business. His appointment comes at a pivotal time as the company seeks to unlock shareholder value. The transition will be facilitated by working alongside the current CFO, Ms. Ancila Desai, ensuring a smooth handover.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Solutions (ASX: MDR) is a leader in pharmacy-driven patient engagement solutions, offering personalized experiences to simplify the medication journey. Utilizing THRiV, a cloud-based, AI-enabled platform, the company enhances pharmacy workflow and patient engagement. MedAdvisor Solutions collaborates with over 34,000 pharmacies in the US, reaching over two-thirds of the population.
Average Trading Volume: 1,050,975
Technical Sentiment Signal: Sell
Current Market Cap: A$37.52M
For detailed information about MDR stock, go to TipRanks’ Stock Analysis page.